Name: Mohammad Alhazmi

Occupation: Final Year Medicine Student

Institution: Royal College of Surgeons in Ireland

 

1. What are you currently using CELLINK technology for?

 

We are currently using different bioinks bought from CELLINK (CELLINK Bioink and CELLINK RGD) to optimise particular functional structures. Areas of interest include but not limited to cartilage regeneration and diabetic ulcers.

 

2. What sparked your interest to work with 3D Bioprinting?

 

I am in my final year in medicine and will be pursuing a career in orthopedic surgery, throughout my medical school years, I have a found myself quite fond of medical physics and biomedical engineering. I was reading several articles online and I saw how 3D printing and 3D Bioprinting is an advancing technology and I can see that it does have a very bright future. I decided to undergo a project in RCSI Bahrain where they have a team of experts working with 3D Bioprinting. I expressed my interest and worked with them for 6 months which made aware that this is definitely an interesting field that I can potentially work on once I graduate. I can see the potential for bioprinting to be implemented within the surgical area in the future.

 

3. What future projects are you hoping to use CELLINK technology for?

There is a potential project designed to optimise structures similar to blood vessels in structure, function and physiology. This is potentially something that will be worked on once I graduate form medical school.

 

4. What do you find to be most exciting about working with 3D Bioprinting?

The idea that is most appealing and exciting is that maybe in 10 or 20 years, many people actually can benefit from this technology. Now, it may be hard to believe that 3D bioprinted organs can be transplanted with the patient’s own cells in a decade or two but this is the plan and this where the industry is moving towards eventually. Bioprinting is not a technology that should be overlooked. This technology is already making a great impact in the world of biotech and it’s obvious the potential is far greater than the public realizes. Getting to work with bioprinting and CELLINK technology has shined a light on just how important this field is. I look forward to continuing my work within this field and making a difference in the world.